恩华药业前三季度净利11.06亿元，同比增长8.42%

Core Viewpoint - Enhua Pharmaceutical reported a revenue of 4.471 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 7.85% [1] - The net profit attributable to shareholders reached 1.106 billion yuan, marking an increase of 8.42% compared to the previous year [1] Financial Performance - Revenue for the first three quarters: 4.471 billion yuan, up 7.85% year-on-year [1] - Net profit attributable to shareholders: 1.106 billion yuan, up 8.42% year-on-year [1]